top of page

Sponsors

For more information on our research site or Sponsor / CRO inquiries, please contact:

Tony Ortiz, Ph.D. 

Scientific Director

(714) 335-3015

tortiz@nrcresearch.com​​

Christian Ortiz

Business Development Specialist

(949) 659-6263

cortiz@nrcresearch.com

You may also use the inquiry form to contact us.

Interested in conducting a clinical trial at our research site?

Please fill in the inquiry form below, and we will be in contact with you shortly.

Your message has been submitted. Thank you for contacting us!

53424_voinv_catalyst site_banners_psychi

At a Glance

 

  • Conduct phase I-IV inpatient and outpatient clinical studies for various medical and CNS indications

  • 3 locations, including a 25 bed inpatient facility

  • Able to "Fast-Track" study start-up by using centralized IRB and guaranteeing "First Patient-In" for various sponsors

  • Strong history of exceeding contracted enrollment expectations

  • Screen-failure rate varies between 12-25% depending on indication

  • Completion rate is between 80-100%

  • Raters are specifically trained to manage placebo-response

  • Recruitment is focused around internal patient database and outpatient clinic--advertisement funds are rarely used

  • Internal quality assurance group ensures proper conduct and documentation of studies

  • GCP/ICH training is conducted at least twice per year

What We Do

 

We are a dedicated research facility with locations in Southern California, with a mission to obtain quality clinical research data in order to advance safe and effective therapeutics to the marketplace. 

 

Our team of highly trained board-certified psychiatrists, psychologists, physicians, and experienced clinical research coordinators ensure that we obtain the best data possible for our sponsors. Our investigators and clinical staff adhere to the standards of GCP and ICH guidelines.

 

Our expertise has evolved into long-term inpatient trials for the diseased population that requires complex study procedures, such as pharmacokinetics (PK), pharmacodynamics (PD), cardiac safety, ascending dosages, food interaction, and mechanism of action.

 

We have developed investigator-initiated studies for various sponsors that incorporated polysomnography, high-field MRI and PET scans.  We have assisted in the development of protocols and research designs for various trials.

Facilities

​

Global HQ - Center for Neuroscience

(714) 289-1100

1010 West Chapman Avenue 
Orange, CA 92868

​

Our founding facility, located in Orange, CA. To learn more about this facility and its capabilities, click below.

​

​

 

The Research Center for Inclusion and Diversity

​(213) 992-9216

1400 South Grand Ave Suite 611

Los Angeles, CA 90015

​

Our newest facility, located in the heart of Downtown Los Angeles, CA. To learn more about this facility and its capabilities, click below. 

​

​

 

Early Phase Research Unit

(714) 289-1100

Santa Ana, CA 92705

​

Our Early Phase Research Unit is an elite inpatient facility located in Santa Ana. To learn more about this facility and its capabilities, see below.

Early Phase Research Unit

Early Phase Research Unit is NRC's elite inpatient facility located in Santa Ana, CA. For our studies that require overnight stays, participants can look forward to staying in a comfortable place and with multiple amenities.

Inpt Unit

Capabilities

Our Early Phase Research Unit facility contains the following:

 

  • 25 Beds specifically for clinical trials

  • The Unit is sub-divided for adolescents and adults

  • Neurocognition lab for neuropsychological assessment

  • Exam rooms with calibrated EKG/vitals equipment

  • Laboratory with a refrigerated centrifuge

  • -20 degree and -70 degree freezer for PK samples

  • Onsite infusions

  • Entertainment area for patient use

  • Wi-Fi provided for patients

  • Double-locked drug room

  • Crash cart on site

OUR SPONSORS

Abbvie-clinical-trials-california
Acadia-Clinical-Research-California
Acerta-Clinical-Trials-California
Aevi-clinical-research-orange
Alkermes-southern-california-studies
Aptinyx-clinical-research-orange
AstraZeneca-clinical-research
Allergan-southern-california
Auspex-southern-california
Avanir-clinical-research-orange
Baxter
Biogen
Biohaven Pharmaceuticals
bioxcel_therapeutics_logo
Boehringer Ingelheim
Bristol-Myers-Squibb
Curemark
Daiichi-Sankyo
Dare logo
Dr. Reddy's
Eisai
Elan
Evotec
Forest
Forum
Genentech
Incyte
Indivior
Intra-Cellular
Janssen
Johnson & Johnson
Karuna Therapeutics
Eli Lilly
Lundbeck
Shandong Luye
Medgenics
Merck
Novartis
Otsuka
Palatin
Pfizer
Pharmascience
Purdue
Roche
Regeneron
rovi_logo
Sage
Shionogi
Shire
STS Logo
Sunovion
Supernus
SyneuRx
Taisho
Takeda
Targacept
TEVA
Tonix Clinical Trials California

OUR CROs

Abbvie
advarra-logo
ACM
Allergan
Amarex
Avanir
Boehringer Ingelheim
Cognitive Research Corporation
ICON
IQVIA
INC
Inventiv
Janssen
Linical Accelovance
Medsource
Merck
Novartis
Parexel
PRA
Premier Research
Quintiles
SGS
Syneos Health
Target Health Inc
WWCT
bottom of page